Endothelial dysfunction and inflammation after percutaneous coronary intervention

Arnon Blum1, David J Schneider, Burton E Sobel

  • 1Department of Internal Medicine A, Poria Medical Center, Lower Galilee, Israel.

Insights

Coronary stenting patients with impaired endothelium-dependent dilation showed higher C-reactive protein levels, indicating a link between systemic inflammation and endothelial dysfunction after the procedure.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Inflammation Research

Background:

  • Endothelial dysfunction is a key factor in cardiovascular disease.
  • Coronary stenting can impact endothelial function.
  • Systemic inflammation, indicated by cytokines like C-reactive protein (CRP), plays a role in vascular health.

Purpose of the Study:

  • To investigate the relationship between post-procedure endothelial dysfunction and cytokine levels in patients undergoing coronary stenting.
  • To determine if abnormalities in endothelium-dependent and endothelium-independent vasodilation are associated with systemic inflammation.

Main Methods:

  • Studied 30 consecutive patients undergoing coronary stenting.
  • Assessed pre- and post-procedure endothelial function, specifically flow-mediated dependent and independent dilation.
  • Measured pre- and post-procedure C-reactive protein (CRP) levels as a marker of systemic inflammation.

Main Results:

  • Patients with severe endothelium-dependent dilation impairment had significantly higher CRP levels before and after stenting compared to those without severe abnormalities.
  • No significant association was found between endothelium-independent dilation abnormalities and systemic inflammatory status (CRP levels).

Conclusions:

  • Abnormalities in endothelium-dependent vasodilation following coronary stenting are linked to the patient's systemic inflammatory state.
  • Endothelium-independent vasodilation appears unaffected by the systemic inflammatory status in this patient cohort.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...